MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

MS Auckland Webinar: Remyelination Research in MS

MStranslate
April 15, 2026
Cambridge, Remyelination, Research
two doctors, a man and a woman, examine an MRI image of the brain

FDA Decision On Tolebrutinib

MStranslate
January 12, 2026
Clinical Trials
A pair of hands around a crystal ball that has the year 2026 written inside it.

Multiple Sclerosis Research In 2026

MStranslate
January 5, 2026
Progressive MS, Remyelination, Treatments
ECTRIMS Congress 2025

Revisiting ECTRIMS Congress 2025

MStranslate
November 18, 2025
ECTRIMS, Podcasts, Research
The ECTRIMS Podcast

UPDATED: The ECTRIMS Podcast – Episode Library

MStranslate
September 10, 2025
ECTRIMS, Podcasts, Research
myelin repair

Fasting & Metformin Improve Myelin Repair

MStranslate
October 9, 2019
Remyelination, Research, Videos
4 Comments
A newly published study from the University of Cambridge has found that fasting, as well as a common diabetes drug that mimics fasting, can improve myelin repair. In the below video, our co-founder and...
ECTRIMS 2019

ECTRIMS 2019: Review of Online Coverage

MStranslate
September 18, 2019
Conferences, ECTRIMS
While ECTRIMS 2019 is officially over, our coverage of it will continue during the coming weeks.  There are three reasons for this.  Firstly, there was just too much content to cover in our short end of day...
ECTRIMS 2019

ECTRIMS 2019: Final Thoughts From Stockholm

MStranslate
September 13, 2019
Dr Travis Stiles, ECTRIMS, Research
ECTRIMS 2019 has officially ended.  It is safe to say that it was a huge three days and I am exhausted!  I really hope that you have enjoyed the video summaries from Day 1 and Day 2.  With the conference...
Quality of Life

Improving Quality of Life in Multiple Sclerosis

MStranslate
August 28, 2019
Quality of Life, Research, Symptoms
2 Comments
Recently, I arrived in the United Kingdom and headed north to the city of Liverpool.  While I’m a fan of The Beatles and a passionate Liverpool Football Club supporter in the Premier League, I had other...
Facebook Live

Facebook Live: Announcement & Research Update

MStranslate
August 16, 2019
Community, Q&A, Research
In our most recent Facebook Live Q&A, once again facilitated by our co-founder and chief science communicator, Brett Drummond, a special announcement was made. We were excited to share that, for the second...
MS: Many Stories

MS: Many Stories – Managing MS Through Lifestyle

MStranslate
August 2, 2019
Community, MS: Many Stories
1 Comment
It is fantastic to once again be able to revisit our MS: Many Stories series, where members of the MStranslate community share their personal insights and experiences of living with multiple sclerosis.  This...
cognition

Does Age of MS Onset Impact on Cognition?

MStranslate
June 26, 2019
Cognition, Research, Symptoms
1 Comment
Research Summary: Long-term Cognitive Outcomes in Patients With Pediatric-Onset vs Adult-Onset Multiple Sclerosis Ask people living with multiple sclerosis what their worst symptom is and they will probably...
body mass index

Body Mass Index (BMI) Linked to Brain Volume Loss

MStranslate
June 18, 2019
Lifestyle, Research
There is an increasing focus on the role that lifestyle changes may play in helping to manage multiple sclerosis. Factors such as diet, exercise, mindfulness, vitamin D levels and smoking habits are all...
World MS Day

Facebook Live: World MS Day Research Update

MStranslate
June 11, 2019
Research, Videos
On World MS Day 2019 (May 29), MStranslate co-founder and chief science communicator, Brett Drummond, took to Facebook Live to provide a comprehensive update on the latest developments in multiple sclerosis...
gut bacteria

Treatment With Gut Bacteria Shows Benefits In New Study

MStranslate
May 2, 2019
Research, Treatments
1 Comment
Research Summary: Prevotella histicola, A Human Gut Commensal, Is as Potent as COPAXONE® in an Animal Model of Multiple Sclerosis Many people living with multiple sclerosis say they have experienced...
  1. 6
  2. 7
  3. 8
  4. 9
  5. 10
  6. 11
  7. 12

Recent Posts

  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library

Recent Comments

  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date
  • Treatment With Gut Bacteria Shows Benefits In New Study on Gut Bacteria in People Living with RRMS
  • Community Q&A: COVID-19 Vaccines & Multiple Sclerosis on Community Q&A: The Blood-Brain Barrier
  • Community Q&A: Why Don't We Have A Multiple Sclerosis Cure? on Community Q&A: COVID-19 Vaccines & MS
  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS

Calendar

June 2026
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
« Apr    

Archives

Categories

Posts

  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.